Kim ES, Tkatch R, Martin D, MacLeod S, Sandy L, Yeh C. Resilient aging: psychological well-being and social well-being as targets for the promotion of healthy aging. Gerontol Geriatr Med. 2021 Mar 23;7:233372142. doi: 10.1177/23337214211002951
Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Tkatch R, Musich S, MacLeod S, Alsgaard K, Hawkins K, Yeh CS. Population health management for older adults: review of interventions for promoting successful aging across the health continuum. Gerontol Geriatr Med. 2016 Sep 18;2:233372141. doi: 10.1177/2333721416667877
Musich S, MacLeod S, Bhattarai GR, Wang SS, Hawkins K, Bottone, Jr. FG, Yeh CS. The impact of obesity on health utilization and expenditures in a medicare supplement. Gerontol Geriatr Med. 2016 Jan 19;2:233372141. doi: 10.1177/2333721415622004
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.